Assad Moon

Mr. Assad Moon

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
ZDZhong Dailang
Zhong Dailang
ZLZhanhao Lu
Zhanhao Lu
YXYu Xia
Yu Xia
HWHongxia Wu
Hongxia Wu
XZXinyu Zhang
Xinyu Zhang
SYSun Yuan
Sun Yuan
Classical swine fever (CSF), caused by the classical swine fever virus (CSFV), results in significant economic losses to the swine industry in many countries. Vaccination represents the primary strategy to control CSF and the CSFV E2 protein is known as the major protective antigen. However, the E2 protein expressed or presented by different systems elicits distinct immune responses. In this study, we established a stable CHO cell line to express the E2 protein and delivered it using self-assembled ferritin nanoparticles (NPs). Subsequently, we compared the adaptive immune responses induced by the E2-ferritin NPs and the monomeric E2 protein produced by the CHO cells or a baculovirus expression system. The results revealed that the NP-delivered E2 protein elicited higher titers of neutralizing antibodies than did the monomeric E2 protein in pigs. Importantly, only the NP-delivered E2 protein significantly induced CSFV-specific IFN-γ-secreting cells. Furthermore, all the pigs inoculated with the E2-ferritin NPs were completely protected from a lethal CSFV challenge infection. These findings demonstrate the ability of the E2-ferritin NPs to protect pigs against the lethal CSFV challenge by eliciting robust humoral and cellular immune responses.

26 October 2022 in Applied Microbiology
Verified
Journal Article
Open access
PDF file
Assad MoonAssad Moon
Assad Moon
SYSun Yuan
Sun Yuan
YWyanjin wang
yanjin wang
JHJingshan Huang
Jingshan Huang
MKMuhammad Umar Zafar Khan
Muhammad Umar Zafar Khan
Hua-Ji QiuHua-Ji Qiu
Hua-Ji Qiu
Mucosal vaccination offer an advantage over systemic inoculation from the immunological viewpoint. The development of an efficient vaccine is now a priority for emerging diseases such as COVID-19, that was declared a pandemic in 2020 and caused millions of deaths globally. Lactic acid bacteria (LAB) especially Lactobacillus are the vital microbiota of the gut, which is observed as having valuable effects on animals’ and human health. LAB produce lactic acid as the major by-product of carbohydrate degradation and play a significant role in innate immunity enhancement. LAB have significant characteristics to mimic pathogen infections and intrinsically possess adjuvant properties to enhance mucosal immunity. Increasing demand and deliberations are being substantially focused on probiotic organisms that can enhance mucosal immunity against viral diseases. LAB can also strengthen their host’s antiviral defense system by producing antiviral peptides, and releasing metabolites that prevent viral infections and adhesion to mucosal surfaces. From the perspectives of “one health” and the use of probiotics, conventional belief has opened up a new horizon on the use of LAB as antivirals. The major interest of this review is to depict the beneficial use of LAB as antivirals and mucosal immunity enhancers against viral diseases.

24 July 2024 in Viruses
Verified
Journal Article
Open access
PDF file
Assad MoonAssad Moon
Assad Moon
JHJingshan Huang
Jingshan Huang
XSXin Song
Xin Song
TWTao Wang
Tao Wang
YWyanjin wang
yanjin wang
Hua-Ji QiuHua-Ji Qiu
Hua-Ji Qiu
Pseudorabies virus (PRV) is one of the herpes viruses that can infect a wide range of animals including pigs, cattle, sheep, mice, and wild animals. PRV is a neurotropic alphaherpesvirus capable of infecting a variety of mammals. There is a rising interest in the targeted application of probiotic bacteria to prevent viral diseases, including PRV. In this study, the surface expression of enhanced green fluorescent protein (EGFP) on recombinant Lactiplantibacillus plantarum NC8 (rNC8) through the LP3065 LPxTG motif of Lactobacillus plantarum WCFS1 was generated. The surface expression was observed through confocal microscopy. Dendritic cell targeting peptides (DCpep) were also fused with LPxTG that help to bind with mouse DCs. The PRV-gD was cloned in LP3065 LPxTG, resulting in the generation of rNC8-LP3065-gD. Inactivated rNC8-LP3065-gD was administered intravenously in mice on days 1 and 7 at a dose of 200 µL (109 CFU/mouse) for monitoring immunogenicity. Subsequently, a challenge dose of PRV TJ (104 TCID50) was administered intramuscularly at 14 days post-immunization. The survival rate of the immunized mice reached 80% (4/5) with no significant signs of illness. A significant rise in anti-gD antibodies was detected in the immunized mice by ELISA. Quantitative PCR (qPCR) results showed decreased viral loading in different body tissues. Flow cytometry of lymphocytes derived from mice spleen indicated an increase in CD3+CD4+ T cells, but CD3+CD8+ T cells were not detected. Moreover, it offers a model to delineate immune correlates with rNC8-induced immunity against swine viral diseases.

24 December 2024 in Vaccines
Verified
Journal Article
Open access
JHJingshan Huang
Jingshan Huang
HWHongxia Wu
Hongxia Wu
TGTianqi Gao
Tianqi Gao
HZHuanjie Zhai
Huanjie Zhai
Assad MoonAssad Moon
Assad Moon
SYSun Yuan
Sun Yuan
Background/Objectives: African swine fever (ASF), caused by African swine fever virus (ASFV), poses a significant threat to the global swine industry. This underscores the urgent need for safe and effective ASF vaccines. Methods: Here, we constructed five bacterium-like particles (BLPs) that each display one of the five ASFV antigens (F317L, H171R, D117L, B602L, and p54) based on the Gram-positive enhancer matrix-protein anchor (GEM-PA) system. GEM is a bacterial particle that contains only peptidoglycan, while PA is composed of three lysin motifs (Lysm) derived from the C-terminus of the AcmA protein, capable of non-covalently binding to GEM. By fusing the ASFV antigens with PA, the ASFV antigens can be firmly attached to the surface of GEM. Subsequently, the piglets were immunized via intramuscular injection with a mixture of BLPs-F317L, BLPs-H171R, BLPs-D117L, BLPs-B602L, and BLPs-p54. Results: The results showed that the piglets developed detectable serum IgG antibodies 2 weeks after the first immunization, and these high antibody levels were maintained 4 weeks after the booster immunization. Moreover, these piglets produced more IFN-γ-producing lymphocytes than the control piglets. Conclusions: The data indicate that the generated BLPs mixture can stimulate both humoral and cellular immune responses in piglets, these five ASFV proteins are promising antigens, and the BLPs generated represent candidate ASF vaccines.

25 August 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
Assad MoonAssad Moon
Assad Moon
HWHongxia Wu
Hongxia Wu
TWTao Wang
Tao Wang
Lian-Feng LiLian-Feng Li
Lian-Feng Li
YLYongfeng Li
Yongfeng Li
Hua-Ji QiuHua-Ji Qiu
Hua-Ji Qiu
Background: African swine fever (ASF) is a highly contagious and often deadly disease that poses a major threat to swine production worldwide. The lack of a commercially available vaccine underscores the critical need for innovative immunization strategies to combat ASF. Methods: Six ASFV antigenic proteins (K78R, A104R, E120R, E183L, D117L, and H171R) were fused with the Lactiplantibacillus plantarum WCFS1 surface anchor LP3065 (LPxTG motif) to generate recombinant Lactiplantibacillus plantarum NC8 (rNC8) strains. The surface expression was confirmed using immunofluorescence and Western blotting assays. Additionally, the dendritic cell-targeting peptides (DCpep) were co-expressed with each antigen protein. Mice were immunized at a dosage of 109 colony-forming units (CFU) per strain per mouse via intragastric (I.G.), intranasal (I.N.), and intravenous (I.V.) routes. The bacterial mixture was heat-inactivated by boiling for 15 min to destroy viable cells while preserving antigenic structures. I.V. administration caused no hypersensitivity, confirming the method’s safety and effectiveness. Results: Following I.G. administration, rNC8-E120R, rNC8-E183L, rNC8-K78R, and rNC8-A104R induced significant levels of secretory immunoglobulin A (sIgA) in fecal samples, whereas rNC8-H171R and rNC8-D117L failed to induce a comparable response. Meanwhile, rNC8-D117L, rNC8-K78R, and rNC8-A104R also elicited significant levels of sIgA in bronchoalveolar lavage fluid (BALF). Following I.N. immunization, rNC8-E120R, rNC8-K78R, and rNC8-A104R significantly increased sIgA levels in both fecal and BALF immunization. In contrast, I.V. immunization with heat-inactivated rNC8-K78R and rNC8-A104R induced robust serum IgG titers, whereas the remaining antigens elicited minimal or insignificant responses. Flow cytometry analysis revealed expanded CD3+CD4+ T cells in mice immunized via the I.N. and I.G. and CD3+CD4+ T cells only in those immunized via the I.N. route. Th1 responses were also significant in the sera of mice immunized via the I.G. and I.N. routes. Conclusions: The rNC8 multiple-antigen cocktail elicited strong systemic and mucosal immune responses, providing a solid foundation for the development of a probiotic-based vaccine against ASF.

21 May 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Assad MoonAssad Moon
Assad Moon
HWHongxia Wu
Hongxia Wu
TWTao Wang
Tao Wang
LLLianfeng Li
Lianfeng Li
YLYongfeng Li
Yongfeng Li
Hua-Ji QiuHua-Ji Qiu
Hua-Ji Qiu
Background: African swine fever (ASF) is a deadly, highly contagious disease with major global pig industry impacts, highlighting the urgent need for an effective vaccine. Methods: In this study, six antigenic proteins (K78R, A104R, E120R, E183L, D117L, and H171R) of ASFV were fused with the LPxTG surface anchoring polypeptide i.e., LP3065 of Lactobacillus plantarum WCFS1, resulting in the generation of the recombinant Lactiplantibacillus plantarum NC8 (rNC8) strains. The surface expression of ASFV antigenic proteins was confirmed by immunofluorescence and Western blotting assays. The peptides (DCpep) targeting dendritic cells (DCs) were also fused with LP3065 to bind to mouse DCs. The recombinant strains were administered via intragastric (I.G.), intranasal (I.N.), and intravenous (I.V.) routes in mice at 109 CFU/mouse. Results: In the I.V. immunized mice, the higher IgG titers were induced by rNC8-K78R and rNC8-A104R, while rNC8-E120R, rNC8-E183L, rNC8-D117L, rNC8-H171R induced low IgG titers, and rNC8-E120R remained insignificant. In the I.G. immunized mice, rNC8-E120R, rNC8-E183, rNC8-K78R, and rNC8-A104R induced higher sIgA levels, while rNC8-H171R and rNC8-D117L remained not significant in the feces. In the bronchioalveolar lavage fluid (BALF) of the I.G. immunized mice, rNC8-D117L, rNC8-K78R, and rNC8-A104R induced higher levels of sIgA, while rNC8-E120R, rNC8-E183L, and rNC8-H171R were insignificant. In the feces of the I.N. immunized mice, rNC8-E120R, rNC8-K78R, and rNC8-A104R induced higher levels of sIgA, while rNC8-D117L remained insignificant. In the BALF of the I.N. immunized mice, rNC8-E120R, rNC8-K78R, and rNC8-A104R induced higher sIgA levels, while rNC8-H171R remained insignificant. Th1 (IFN-γ and IL-2) and Th2 (IL-4 and IL-10) responses were significant in the sera of the I.G. and I.N. immunized mice, whereas IL-10 levels remained insignificant in both groups. Flow cytometry showed a significant increase in CD3+CD4+ T cells in both the I.N. and I.G. groups, while CD3+CD8+ T cells were elevated only in the I.N. group compared with the control groups. Conclusion: This multiple antigen cocktail represents a probiotic-based ASF vaccine candidate that warrants further evaluation.